
Prior Learning for Phase I Courses
The process for recognizing prior learning for Phase I courses is about the same as if you were transferring credit for a course earned at one university to another university. It is the student's responsibility to explain the desired course in sufficient detail to allow the instructor to evaluate whether or not the course (and perhaps life experience) meets our definition of our Phase I courses. It is the course instructor's responsibility to determine whether the submissions sufficiently meets the course requirements.
Here are our Phase I Prerequisite Basic Knowledge Courses (and their UW & WSU equivalents):
- Pharm 493, Medical Literature Evaluation, 2 quarter credit (UW) or PharP 558, Drug Information Retrieval and Evaluation, 1 semester credit (WSU);
- Pharm 479, Quantitative Methods 2, 4 quarter credit (UW) or PharP 531, Clinical Research Methods, 3 semester credit (WSU). This is largely a general statistics course;
- Pharm 494, Introduction to Pharmacokinetics, 2 quarter credit (UW) or PharP 557, Clinical Pharmacokinetics, 2 semester credit (WSU). These are clinical or applied pharmacokinetics courses taken after a basic pharmacokinetics course.
Here is what the instructors need (taken from our Student Handbook on Prior Learning Assessment)
- Requests for Recognition of Learning fulfilling the Phase I Prerequisite Courses (use a separate page for each course):
- Attach a course outline or syllabus which contains the following information: the nature and content of information covered, the text book used, the institution at which the course was taken, the calendar year the course or experience was completed, and a reference to proof of successful completion such as a certificate or university transcript.
- If you do not have a course outline write an explanation, not to exceed one page in length, describing the information above.
- For the Medical Literature Evaluation course, you will need to demonstrate a successful critique of two different types of primary literature: a randomized, controlled trial (RCT), and some kind of pharmacoepidemiology study. In your critique you will briefly outline the study and then comment on strengths and limitations. If you have examples from past articles or journal clubs you have led, those may provide adequate examples of your ability to understand and evaluate medical literature. If you do not have examples from past work, you are welcome to submit a write-up of an RCT and pharmacoepidemiology study of your choice using the recommended format.
- For the Pharmacokinetics course, the instructor has determined that an undergraduate course in pharmacokinetics will not substitute for our PharmD level course. NEW!
The requests should be directed to the director of the program, NOT the course instructor. There is no charge for this process.
Stanley S. Weber, Pharm.D, FASHP, BCPP
Director, Joint Doctor of Pharmacy Degree Program
University of Washington and Washington State University
Copyright © 2007
Comments:
expharmd@u.washington.edu
Revised: October 2007